Thalys(603716)

Search documents
医疗耗材供应链SPD板块10月15日涨1.95%,塞力医疗领涨,主力资金净流入4097.77万元
Sou Hu Cai Jing· 2025-10-15 09:01
从资金流向上来看,当日医疗耗材供应链SPD板块主力资金净流入4097.77万元,游资资金净流出5500.59 万元,散户资金净流入1402.82万元。医疗耗材供应链SPD板块个股资金流向见下表: | 代码 | 名称 | 主力净流入(元) | 主力净占比 游资净流入(元) | | 游资净占比 散户净流入 (元) | | 散户净占比 | | --- | --- | --- | --- | --- | --- | --- | --- | | 603716 | 塞力医疗 | 7151.75万 | 7.01% | -3856.80万 | -3.78% | -3294.95万 | -3.23% | | 603368 柳药集团 | | 919.87万 | 7.23% | -1249.48万 | -9.82% | 329.61万 | 2.59% | | 000503 | 国新健康 | 811.88万 | 5.12% | 79.12万 | 0.50% | -891.00万 | -5.61% | | 600511 | 国药股份 | 367.52万 | 3.34% | 1026.75万 | 9.34% | -1394.28万 | ...
医药商业板块10月15日涨1%,塞力医疗领涨,主力资金净流入1.56亿元
Zheng Xing Xing Ye Ri Bao· 2025-10-15 08:37
Market Overview - The pharmaceutical commercial sector increased by 1.0% on October 15, with Saili Medical leading the gains [1] - The Shanghai Composite Index closed at 3912.21, up 1.22%, while the Shenzhen Component Index closed at 13118.75, up 1.73% [1] Stock Performance - Saili Medical (603716) closed at 26.86, with a rise of 7.31% and a trading volume of 384,800 shares, amounting to a transaction value of 1.02 billion [1] - Baiyang Pharmaceutical (301015) rose by 4.16% to close at 27.28, with a trading volume of 49,900 shares and a transaction value of 134 million [1] - Huaren Health (301408) increased by 2.70% to close at 12.94, with a trading volume of 57,600 shares and a transaction value of 7.41 million [1] - Other notable stocks include Yiyang Pharmaceutical (2.28% increase) and Yaoyigou (1.87% increase) [1] Capital Flow - The pharmaceutical commercial sector saw a net inflow of 156 million from institutional investors, while retail investors experienced a net outflow of 1.04 billion [2] - The main stocks with significant net inflows include Saili Medical (71.52 million) and Shanghai Pharmaceutical (49.55 million) [3] - Retail investors showed a notable outflow from Shanghai Pharmaceutical, with a net outflow of 63.13 million [3]
A股创新药概念股集体走强,广生堂涨近18%,舒泰神涨超12%
Ge Long Hui A P P· 2025-10-15 06:37
MACD金叉信号形成,这些股涨势不错! | 代码 | 名称 | | 涨幅% ↓ | 总市值 | 年初至今涨幅%。 | | --- | --- | --- | --- | --- | --- | | 300436 | 广牛堂 | + | 17.95 | 192亿 | 269.02 | | 300204 | 舒泰神 | + | 12.44 | 173亿 | 389.07 | | 603222 | 济民健康 | | 10.03 | 57.60亿 | 61.56 | | 002940 | 昂利康 | | 10.01 | 83.11亿 | 213.50 | | 600513 | 联环药业 | 1 | 10.00 | 59.66亿 | 112.97 | | 600521 | 华海药业 | | 9.20 | 314亿 | 18.92 | | 688221 | 前沿牛物-L * | | 8.66 | 55.44亿 | 51.64 | | 300199 | 翰宇药业 | - | 7.37 | 192亿 | 68.35 | | 603716 | 塞力医疗 | 源 | 6.99 | 56.28亿 | 270.91 | | 6034 ...
创新药概念股震荡拉升 昂利康涨停
Shang Hai Zheng Quan Bao· 2025-10-15 04:53
Core Viewpoint - The innovative drug concept stocks experienced a significant surge in early trading on October 15, with several companies reaching their daily price limits and notable increases in stock prices [1]. Group 1: Stock Performance - Angli康 reached the daily limit up, indicating strong investor interest [1]. - Guangshengtang saw a rise of over 10%, with a notable increase of 14.41% in its stock price [2]. - Other companies such as Saili Medical, Shutaishen, Rongchang Bio, and Lianhuan Pharmaceutical also experienced substantial gains, contributing to the overall positive trend in the innovative drug sector [1]. Group 2: Notable Stock Increases - Guangshengtang (300436) reported a stock increase of 116.94%, with a rise of 14.41% [2]. - Pinlikang (002940) increased by 41.20%, with a rise of 10.01% [2]. - Saili Medical (603716) saw a 27.12% increase, with an 8.35% rise [2]. - Shutaishen (300204) experienced a 34.77% increase, with a 7.88% rise [2]. - Jimin Health (603222) rose by 10.64%, with a 6.72% increase [2]. - Lianhuan Pharmaceutical (600513) increased by 20.21%, with a 6.37% rise [2]. - Rongchang Bio (688331) saw a 97.06% increase, with a 6.31% rise [2]. - Zhendong Pharmaceutical (300158) increased by 6.95%, with a 5.95% rise [2]. - Kangchen Pharmaceutical (035500) rose by 48.68%, with a 4.91% increase [2]. - Maiwei Niwu-U (688062) saw a 46.58% increase, with a 4.86% rise [2].
塞力医疗股价涨5.55%,财通基金旗下1只基金位居十大流通股东,持有64.34万股浮盈赚取89.43万元
Xin Lang Cai Jing· 2025-10-15 02:20
10月15日,塞力医疗涨5.55%,截至发稿,报26.42元/股,成交2.46亿元,换手率4.62%,总市值55.53亿 元。 资料显示,塞力斯医疗科技集团股份有限公司位于湖北省武汉市东西湖区金山大道1310号,成立日期 2004年2月23日,上市日期2016年10月31日,公司主营业务涉及医疗检验集约化营销及服务业务、体外 诊断产品的代理以及自主体外诊断产品的研发、生产和销售。主营业务收入构成为:IVD业务39.91%, SPD业务38.01%,单纯销售22.08%。 从塞力医疗十大流通股东角度 数据显示,财通基金旗下1只基金位居塞力医疗十大流通股东。财通优势行业轮动混合A(011201)二 季度新进十大流通股东,持有股数64.34万股,占流通股的比例为0.34%。根据测算,今日浮盈赚取约 89.43万元。 财通优势行业轮动混合A(011201)成立日期2021年2月9日,最新规模5.36亿。今年以来收益17.35%, 同类排名4543/8161;近一年收益8.66%,同类排名5742/8015;成立以来亏损28.59%。 财通优势行业轮动混合A(011201)基金经理为张胤。 截至发稿,张胤累计任职时间4 ...
医药商业板块10月14日涨0.17%,百洋医药领涨,主力资金净流出1.29亿元
Zheng Xing Xing Ye Ri Bao· 2025-10-14 08:39
Market Overview - The pharmaceutical commercial sector increased by 0.17% on October 14, with Baiyang Pharmaceutical leading the gains [1] - The Shanghai Composite Index closed at 3865.23, down 0.62%, while the Shenzhen Component Index closed at 12895.11, down 2.54% [1] Stock Performance - Baiyang Pharmaceutical (301015) closed at 26.19, up 1.35% with a trading volume of 48,200 shares and a transaction value of 127 million [1] - China Pharmaceutical (600056) closed at 11.26, up 1.26% with a trading volume of 278,600 shares and a transaction value of 313 million [1] - Dazhenlin (603233) closed at 16.81, up 1.14% with a trading volume of 75,200 shares [1] - Other notable performers include Jianfa Zhixin (301584) up 1.01% and Renmin Tongtai (600829) also up 1.01% [1] Capital Flow - The pharmaceutical commercial sector experienced a net outflow of 129 million from institutional investors, while retail investors saw a net inflow of 209 million [2] - The overall capital flow indicates a mixed sentiment, with institutional investors withdrawing funds while retail investors are increasing their positions [2] Individual Stock Capital Flow - Saily Medical (603716) had a net inflow of 27.9 million from institutional investors, but a net outflow of 21.2 million from speculative funds [3] - Jianfa Zhixin (301584) saw a net inflow of 11.02 million from institutional investors, with a net outflow of 9.78 million from speculative funds [3] - Yifeng Pharmacy (603939) had a net inflow of 9.47 million from institutional investors, while retail investors experienced a net outflow of 13.37 million [3]
医疗耗材供应链SPD板块10月10日跌0.4%,塞力医疗领跌,主力资金净流出2.06亿元
Sou Hu Cai Jing· 2025-10-10 09:13
证券之星消息,10月10日医疗耗材供应链SPD板块较上一交易日下跌0.4%,塞力医疗领跌。当日上证指 数报收于3897.03,下跌0.94%。深证成指报收于13355.42,下跌2.7%。医疗耗材供应链SPD板块个股涨跌 见下表: | 代码 | 名称 | 收盘价 | 涨跌幅 | 成交量(手) | 成交额(元) | | --- | --- | --- | --- | --- | --- | | 301126 | 达嘉维康 | 11.34 | 1.89% | 4.30万 | 4865.55万 | | 000411 | 英特集团 | 11.49 | 1.77% | 5.54万 | 6322.58万 | | 603368 | 柳药集团 | 19.20 | 1.75% | 12.10万 | 2.31亿 | | 002589 | 瑞康医药 | 2.86 | 1.06% | 18.36万 | 5238.94万 | | 600272 | 开开实业 | 12.82 | 0.87% | 2.38万 | 3049.50万 | | 603987 | 康德莱 | 9.04 | 0.78% | 5.26万 | 4752.74万 | | ...
塞力斯医疗科技集团股份有限公司2025年第五次临时股东会决议公告
Shang Hai Zheng Quan Bao· 2025-10-09 19:05
证券代码:603716 证券简称:塞力医疗 公告编号:2025-088 登录新浪财经APP 搜索【信披】查看更多考评等级 塞力斯医疗科技集团股份有限公司 2025年第五次临时股东会决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏,并对其内容 的真实性、准确性和完整性承担法律责任。 重要内容提示: ● 本次会议是否有否决议案:无 一、会议召开和出席情况 (一)股东会召开的时间:2025年10月9日 (二)股东会召开的地点:公司(武汉市东西湖区金山大道1310号)A栋A会议室 (三)出席会议的普通股股东和恢复表决权的优先股股东及其持有股份情况: ■ (四)表决方式是否符合《公司法》及《公司章程》的规定,股东会主持情况等。 本次股东会由塞力斯医疗科技集团股份有限公司董事会召集,由公司董事 ■ (三)关于议案表决的有关情况说明 长温伟先生主持。本次会议的召集、召开、表决方式符合有关法律、行政法规、部门规章和《公司章 程》的有关规定。 (五)公司董事和董事会秘书的出席情况 1、公司在任董事9人,出席9人; 2、董事会秘书范莉女士出席本次;其他高管列席本次会议。 二、议案审议情况 ...
塞力医疗(603716) - 可转债转股结果暨股份变动公告
2025-10-09 11:02
塞力斯医疗科技集团股份有限公司 可转债转股结果暨股份变动公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大 遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示: 累计转股情况:截至 2025 年 9 月 30 日,累计已有 23,155.2 万元"塞力 转债"转为公司普通股,累计转股股数为 19,266,619 股,占"塞力转债"转股 前公司总股本的比例为 9.3975%。 未转股可转债情况:截至 2025 年 9 月 30 日,尚未转股的"塞力转债" 金额为 18,797.8 万元,占"塞力转债"发行总量的比例为 34.5987%。 | | | 经上海证券交易所自律监管决定书【2020】306号文同意,公司发行总额为 54,331万元的可转换公司债券于2020年9月15日起在上海证券交易所挂牌交易, 债券简称"塞力转债",债券代码"113601"。 (三)可转换公司债券转股日期及转股价格调整情况 本季度转股情况:"塞力转债"自 2025 年 7 月 1 日至 2025 年 9 月 30 日期间,累计转股金额为 22,983.3 万元,因转股形成的股份数量为 1 ...
塞力医疗(603716) - 国浩律师(上海)事务所关于塞力斯医疗科技集团股份有限公司2025年第五次临时股东会之法律意见书
2025-10-09 11:00
国浩律师(上海)事务所 2025 年第五次临时股东会 关 于 塞力斯医疗科技集团股份有限公司 之 法律意见书 上海市静安区山西北路 99 号苏河湾中心 25-28 楼 邮编:200085 25-28th Floor, Suhe Centre, No.99 West Shanxi Road, Shanghai 200085, China 电话/Tel:+86 21 5234 1668 传真/Fax:+86 21 5243 3320 网址/Website: http://www.grandall.com.cn 2025 年 10 月 国浩律师(上海)事务所 法律意见书 国浩律师(上海)事务所 关于塞力斯医疗科技集团股份有限公司 2025 年第五次临时股东会之法律意见书 致:塞力斯医疗科技集团股份有限公司 塞力斯医疗科技集团股份有限公司(以下简称"公司")2025 年第五次临 时股东会于 2025 年 10 月 9 日召开。国浩律师(上海)事务所(以下简称"本 所")经公司聘请,委派律师出席现场会议,见证公司 2025 年第五次临时股东 会(以下简称"本次股东会")。 本所律师根据《中华人民共和国公司法》《中华人民 ...